πŸ‡ΊπŸ‡Έ FDA
Patent

US 9834513

Benzylamine derivatives

granted A61PA61P1/00A61P1/18

Quick answer

US patent 9834513 (Benzylamine derivatives) held by KalVista Pharmaceuticals Limited expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KalVista Pharmaceuticals Limited
Grant date
Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P1/00, A61P1/18, A61P11/00, A61P13/12